Kinga K. Tomczak, MD, PhD

Tic Disorders and Tourette Syndrome Program, Department of Neurology, Boston Children’s Hospital/Harvard University, Boston, MA · 2 sessions at 1 meeting · 1 upcoming

Topics

Autism & Neurodevelopmental Disorders (2)Child & Adolescent (2)Drug Pipeline & Clinical Trials (2)

Sessions

AACAP Annual Meeting 2026

October 26–31, 2026 · Atlanta, GA · Full program

PosterThe Safety and Effect of Ecopipam During the First 8 Weeks of Tourette’s Disorder Treatment: A Post-Hoc Analysis
October 28, 2026, 13:00–15:00
Post-hoc analysis of the safety and effects of ecopipam over the first 8 weeks of treatment in Tourette's disorder.
Autism & Neurodevelopmental Disorders Child & Adolescent Drug Pipeline & Clinical Trials
PosterLong-Term Safety and Effect of Ecopipam, a Selective Dopamine D1 Receptor Antagonist, in Children, Adolescents, and Adults With Tourette's Disorder
October 28, 2026, 13:00–15:00
Reports long-term safety and efficacy of the D1 antagonist ecopipam in Tourette's disorder across children, adolescents and adults.
Autism & Neurodevelopmental Disorders Child & Adolescent Drug Pipeline & Clinical Trials

Presents with

Donald L. Gilbert (2) · George B. Karkanias (2) · John A. Flatt (2) · Stephen P. Wanaski (2) · Timothy M. Cunniff (2) · Katie Kompoliti · Kevin J. Black · Patricia M. Rice · Tamar C. Katz

Speaker listings come from official conference programs and may change — confirm on each meeting's site. Spot an error? Names printed differently on different programs are merged conservatively.

Kinga K. Tomczak, MD, PhD

Topics

Sessions

AACAP Annual Meeting 2026

Presents with

Browse the directory

By date

By specialty

By location

By type

By audience

Speakers & topics

Recurring meetings